99

Breakthroughs
Sub Categories on Breakthroughs
Latest Articles
Tackling antibiotic resistance when treating pneumonia

Tackling antibiotic resistance when treating pneumonia

JANUARY 18, 2024byUniversity of LiverpoolSchematic summary of the molecular mechanisms in Pseudomonas aeruginosa associated with the observed phenotypic changes in the rabbit model. OprD-associa

Tackling antibiotic resistance when treating pneumonia

JANUARY 18, 2024byUniversity of LiverpoolSchematic summary of the molecular mechanisms in Pseudomonas aeruginosa associated with the observed phenotypic changes in the rabbit model. OprD-associa
Patients regain much weight after stopping new obesity drug: Study

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On
New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma

New data show pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

by European Organisation for Research and Treatment of CancerCredit: Unsplash/CC0 Public DomainNew data from the KEYNOTE-756 phase 3 clinical trial show that adding the immunotherapy drug pembrolizuma
New antibiotic slays deadly superbug in early trial

New antibiotic slays deadly superbug in early trial

by Robin FosterResearchers report that a new type of antibiotic has proved its mettle against a deadly superbug.Acinetobacter baumannii, abacteriathat goes by the nickname CRAB when it bec

New antibiotic slays deadly superbug in early trial

by Robin FosterResearchers report that a new type of antibiotic has proved its mettle against a deadly superbug.Acinetobacter baumannii, abacteriathat goes by the nickname CRAB when it bec
FastGlioma: The AI Model Transforming Glioma Surgery

FastGlioma: The AI Model Transforming Glioma Surgery

Powered by artificial intelligence (AI), FastGlioma offers a new level of precision and efficiency in tumor detection, holding the potential to revolutionize glioma surgery.

FastGlioma: The AI Model Transforming Glioma Surgery

Powered by artificial intelligence (AI), FastGlioma offers a new level of precision and efficiency in tumor detection, holding the potential to revolutionize glioma surgery.
Study supports use of cystic fibrosis drug in infants from four weeks of age

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i

Study supports use of cystic fibrosis drug in infants from four weeks of age

by RCSI University of Medicine and Health SciencesCredit: Pixabay/CC0 Public DomainA cystic fibrosis drug targeting the basic defect that causes the condition has been shown to be safe and effective i
New drug halts growth of aggressive breast cancer in pre-clinical study

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028

New drug halts growth of aggressive breast cancer in pre-clinical study

FEBRUARY 5, 2024by Jessica Stanley,University of AdelaideCDDD11-8 inhibits proliferation of patient-derived breast organoid models. Credit:Oncogene(2023). DOI: 10.1038/s41388-023-028
Uganda study reports first evidence of resistance to vital antimalarial in children with severe malaria

Uganda study reports first evidence of resistance to vital antimalarial in children with severe malaria

byLondon School of Hygiene & Tropical MedicineCredit: Unsplash/CC0 Public DomainMutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in Afri

Uganda study reports first evidence of resistance to vital antimalarial in children with severe malaria

byLondon School of Hygiene & Tropical MedicineCredit: Unsplash/CC0 Public DomainMutations in malarial parasites linked to artemisinin-resistance in Southeast Asia have now been found in Afri
Many antibiotic courses for common infections not in line with guidelines

Many antibiotic courses for common infections not in line with guidelines

by British Medical JournalCredit: CC0 Public DomainMany antibiotic courses prescribed for common infections treated in English primary care (general practices and community services) exceed the r

Many antibiotic courses for common infections not in line with guidelines

by British Medical JournalCredit: CC0 Public DomainMany antibiotic courses prescribed for common infections treated in English primary care (general practices and community services) exceed the r
How does HIV get into the cell's center to kickstart infection?

How does HIV get into the cell's center to kickstart infection?

JANUARY 24, 2024 Editors' notesbyUniversity of New South WalesIntact HIV-1 CLPs penetrate Nup98 condensates via FG-binding pocket. Credit:Nature(2024). DOI: 10.1038/s41586-023-06

How does HIV get into the cell's center to kickstart infection?

JANUARY 24, 2024 Editors' notesbyUniversity of New South WalesIntact HIV-1 CLPs penetrate Nup98 condensates via FG-binding pocket. Credit:Nature(2024). DOI: 10.1038/s41586-023-06
The fate of drug discovery in academia: Why is it so difficult?

The fate of drug discovery in academia: Why is it so difficult?

FEBRUARY 5, 2024by Impact Journals LLCA typical drug discovery and development strategy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28552A new editorial paper titled "The fate

The fate of drug discovery in academia: Why is it so difficult?

FEBRUARY 5, 2024by Impact Journals LLCA typical drug discovery and development strategy. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28552A new editorial paper titled "The fate